Caspase-1 Activation of Interleukin-1ß (IL-1ß) and IL-18 Is Dispensable for Induction of Experimental Cerebral Malaria

Infection and Immunity

Volumn 79, Issue 9, 2011, Pages 3633-3641

  Kordes, Maximilian ^a   Matuschewski, Kai ^a   Hafalla, Julius Clemence R ^b  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MYELOID DIFFERENTIATION FACTOR 88; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOODSTREAM INFECTION; BRAIN MALARIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; ERYTHROCYTE; IMMUNOPATHOLOGY; MOUSE; NONHUMAN; PATHOGENESIS; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPOROZOITE;

ANIMALS; ANTIRHEUMATIC AGENTS; CASPASE 1; DISEASE MODELS, ANIMAL; ERYTHROCYTES; INFLAMMASOMES; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-18; INTERLEUKIN-1BETA; LIVER; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PLASMODIUM BERGHEI; SIGNAL TRANSDUCTION; SPOROZOITES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 80052341059     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05459-11     Document Type: Article

References (51)

1. Adachi, O., et al. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150.
2. Adams, S., H. Brown, and G. Turner. 2002. Breaking down the blood-brain barrier: signaling a path to cerebral malaria? Trends Parasitol. 18:360-366.
3. Amani, V., et al. 2000. Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur. J. Immunol. 30:1646-1655.
4. Bagot, S., et al. 2004. Comparative study of brain CD8+ T cells induced by sporozoites and those induced by blood-stage Plasmodium berghei ANKA involved in the development of cerebral malaria. Infect. Immun. 72:2817-2826.
5. Bazan, J. F., J. C. Timans, and R. A. Kastelein. 1996. A newly defined interleukin-1? Nature 379:591.
6. Belnoue, E., et al. 2002. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J. Immunol. 169:63696375.
7. Belnoue, E., et al. 2008. Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol. 30:544-553.
8. Burns, K., et al. 1998. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273:12203-12209.
9. Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D. V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383:443-446.
10. Coban, C., et al. 2005. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201:19-25.
11. Coban, C., et al. 2007. Pathological role of Toll-like receptor signaling in cerebral malaria. Int. Immunol. 19:67-79.
12. de Souza, J. B., J. C. Hafalla, E. M. Riley, and K. N. Couper. 2010. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology 137:755-772.
13. Dostert, C., et al. 2009. Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One 4:e6510.
14. Dostert, C., et al. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674-677.
15. Engwerda, C. R., et al. 2002. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J. Exp. Med. 195:1371-1377.
16. Fonseca, L., E. Seixas, G. Butcher, and J. Langhorne. 2007. Cytokine responses of CD4+ T cells during a Plasmodium chabaudi chabaudi (ER) blood-stage infection in mice initiated by the natural route of infection. Malaria J. 6:77.
17. Franke-Fayard, B., et al. 2004. A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol. Biochem. Parasitol. 137:23-33.
18. Ghayur, T., et al. 1997. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386:619-623.
19. Grau, G. E., et al. 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237:1210-1212.
20. Griffith, J. W., et al. 2007. Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host. J. Infect. Dis. 196:1553-1564.
21. Griffith, J. W., T. Sun, M. T. McIntosh, and R. Bucala. 2009. Pure hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. J. Immunol. 183:5208-5220.
22. Gu, Y., et al. 1997. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275:206-209.
23. Hafalla, J. C., I. A. Cockburn, and F. Zavala. 2006. Protective and pathogenic roles of CD8+ T cells during malaria infection. Parasite Immunol. 28:15-24.
24. Hannum, C. H., et al. 1990. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-340.
25. Kanneganti, T. D., et al. 2006. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440:233-236.
26. Kopp, E., and R. Medzhitov. 2003. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15:396-401.
27. Kossodo, S., et al. 1997. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 91:536-540.
28. Krishnegowda, G., et al. 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280:8606-8616.
29. Lepenies, B., et al. 2008. Induction of experimental cerebral malaria is independent of TLR2/4/9. Med. Microbiol. Immunol. 197:39-44.
30. Li, P., et al. 1995. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80:401-411.
31. Lyke, K. E., et al. 2004. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum ma-laria and matched uncomplicated malaria or healthy controls. Infect. Immun. 72:5630-5637.
32. Mariathasan, S., et al. 2004. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213-218.
33. Mariathasan, S., et al. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228-232.
34. Medana, I. M., and G. D. Turner. 2006. Human cerebral malaria and the blood-brain barrier. Int. J. Parasitol. 36:555-568.
35. Nagamine, Y., et al. 2003. Involvement of interleukin-18 in severe Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 97:236-241.
36. Parroche, P., et al. 2007. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. U. S. A. 104:1919-1924.
37. Petrilli, V., C. Dostert, D. A. Muruve, and J. Tschopp. 2007. The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 19:615-622.
38. Reimer, T., et al. 2010. Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome. Eur. J. Immunol. 40:764-769.
39. Renia, L., et al. 2006. Pathogenic T cells in cerebral malaria. Int. J. Parasitol. 36:547-554.
40. Robinson, D., et al. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 7:571-581.
41. Schofield, L., and G. E. Grau. 2005. Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 5:722-735.
42. Shio, M. T., et al. 2009. Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog. 5:e1000559.
43. Shornick, L. P., et al. 1996. Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone. J. Exp. Med. 183:1427-1436.
44. Singh, R. P., et al. 2002. The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA. J. Immunol. 168:4674-4681.
45. So, A., T. De Smedt, S. Revaz, and J. Tschopp. 2007. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res. Ther. 9:R28.
46. Takeda, K., et al. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383-390.
47. Takeuchi, O., et al. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451.
48. Togbe, D., et al. 2007. Murine cerebral malaria development is independent of Toll-like receptor signaling. Am. J. Pathol. 170:1640-1648.
49. Torgler, R., et al. 2008. Sporozoite-mediated hepatocyte wounding limits Plasmodium parasite development via MyD88-mediated NF-kappa B activation and inducible NO synthase expression. J. Immunol. 180:3990-3999.
50. van der Heyde, H. C., J. Nolan, V. Combes, I. Gramaglia, and G. E. Grau. 2006. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 22:503-508.
51. World Health Organization. 2009. World malaria report. World Health Organization, Geneva, Switzerland.